Skip to content

Clinical trials

Withdrawn Phase 1/2 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20151
20161
20194
20201
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alan Katz1
Alliance for Clinical Trials in Oncology1
Chongqing Precision Biotech Co., Ltd1
Dana-Farber Cancer Institute1
Devalingam Mahalingam1
Flame Biosciences1
Fuda Cancer Hospital, Guangzhou1
Hitendra Patel1
Johns Hopkins University1
Lisata Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms19
Neoplasms6
Stomach Neoplasms6
Colorectal Neoplasms4
Breast Neoplasms3
Neoplasm Metastasis3
Adenocarcinoma2
Liver Neoplasms2
Lung Neoplasms2
Ovarian Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.